NCT07143695 Parasternal Intercostal Muscle Thickening as an Additive Weaning Criterion
| NCT ID | NCT07143695 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Critically Ill |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2025-09-01 |
| Primary Completion | 2026-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2025-09-01 with a primary completion date of 2026-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Increased days of MV are not without hazards, including barotraumas and ventilator-associated pneumonia. Similarly, premature separation of MV is associated with increased mortality secondary to adverse cardiorespiratory events. Therefore, the time of weaning should be wisely evaluated. There is growing evidence concerning respiratory muscles dysfunction that contributes to difficulty or prolonged liberation from MV.
Eligibility Criteria
Inclusion Criteria: * critically ill patient mechanically ventilated for 24 hours or more first spontaneous breathing trial Exclusion Criteria: * patient refusal difficult ultrasound views tracheostomized patient neuromuscular disorders
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07143695 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Critically Ill. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07143695 currently recruiting?
Yes, NCT07143695 is actively recruiting participants. Contact the research team at kasralainirec@gmail.com for enrollment information.
Where is the NCT07143695 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT07143695 clinical trial?
NCT07143695 is sponsored by Cairo University. The trial plans to enroll 200 participants.